Rapid test for Crimean-Congo Hemorrhagic Fever
Part of Infections clinical trials.
This trial is testing a new rapid blood test to diagnose Crimean-Congo Hemorrhagic Fever (CCHF). It is looking for adults with suspected CCHF who are being treated at specific hospitals in Türkiye.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a suspected case of Crimean-Congo Hemorrhagic Fever (CCHF).
- You are being treated at Sivas Cumhuriyet University or Ondokuz Mayis University in Türkiye.
- You can give a whole blood sample that hasn't been frozen or refrigerated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is developing a quick, point-of-care diagnostic test for Crimean-Congo hemorrhagic fever (CCHF), a serious viral illness. If you have symptoms and are being tested for CCHF, this study could help confirm the diagnosis faster.
This trial tests different treatments for Crimean-Congo hemorrhagic fever (CCHF), a serious viral infection. It aims to find which treatment is safe and works best for patients who are hospitalized with the disease.
This trial is testing an investigational RNA vaccine to see if it is safe and helps your body build immunity against Crimean-Congo hemorrhagic fever, a serious viral disease. The study involves two injections and follow-up visits over several months.
This trial uses a rapid test to find the cause of fever in people who recently returned from tropical areas. It aims to detect new or unusual infections early, when you are still in the emergency department.
This study tests a new rapid diagnostic tool that can quickly identify tropical fever-causing infections like malaria, dengue, Zika, chikungunya, or leptospirosis from a blood sample. The goal is to help doctors diagnose these infections faster so patients can get treatment sooner.
This trial tests a rapid diagnostic method that identifies the bacteria in your blood more quickly than standard tests. If it works, doctors can pick the right antibiotic sooner.
Hear when a new Infectious Diseases, Emerging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.